Keywords: CRC; colorectal cancer; OS; obesity surgery; RYGB; Roux-en-Y gastric bypass; HES; Hospital Episode Statistics; ONS; Office of National Statistics; SIR; standardised incidence ratio; NCRAS; National Cancer Registration & Analysis Service; Bariatric surgery
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Nonalcoholic fatty liver disease; RYGB; Bariatric surgery; Morbid obesity;
Keywords: Endoscopy Gastrointestinal/Adverse Effects; Intestinal Perforation/Diagnosis; Endoscopy Gastrointestinal/Methods; Digestive System Fistula/Surgery; Suture Techniques/Instrumentation; Anastomotic Leak/Surgery, Vacuum Therapy, EndoSPONGE; EVT; endoscopic va
Keywords: Bariatric surgery; EDGB; RYGB; Energy metabolism; Ghrelin; Nesfatin-1;
Keywords: APC; argon plasma coagulation; CI; confidence interval; GMD; gastric mucosal devitalization; RYGB; roux-en-Y gastric bypass; SAT; subcutaneous adipose tissue; SG; sleeve gastrectomy; SH; sham; VAT; visceral adipose tissue;
Keywords: adipose tissue; antiobesity drugs; bariatric surgery; obesity; overweight; weight loss; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; CVOT; cardiovascular outcomes trial; FDA; Food and Drug Administration; HF; heart failure;
Keywords: DIO/DR; CCK; NPY; Amylin; BAT; RYGB; Diabetes; Islet amyloid;
Keywords: bariatric; cardiovascular risk; diabetes; metabolic; obesity; AGB; adjustable gastric banding; BMI; body mass index; BPD; biliopancreatic diversion; BPDDS; biliopancreatic diversion with duodenal switch; CI; confidence interval; HbA1c; glycated hemoglobin
Keywords: MTORC2; Gene expression; RYGB; Obesity; Bariatric surgery;
Keywords: DJBL; duodenal-jejunal bypass liner; GG; gastrogastric; GLP-1; glucagon-like peptide-1; HbA1c; hemoglobin A1c; OR; odds ratio; PYY; peptide YY; RYGB; Roux-en-Y gastric bypass; T2DM; type 2 diabetes mellitus;
Keywords: AACE; American Association of Clinical Endocrinologists; ACA; Patient Protection and Affordable Care Act; ACC; American College of Cardiology; AHA; American Heart Association; AHEAD; Actions for HEAlth in Diabetes; Appy; appendectomy; ASMBS; American Soci
Keywords: RYGB; Roux-en-Y gastric bypass; MGB; mini-gastric bypass; WL; weight loss; NAFLD; non-alcoholic fatty liver disease; BMI; body mass index; NAS; NAFLD activity score; Mini-gastric bypass; Bariatric surgery; Hepatic insufficiency; Non-alcoholic fatty liver
Keywords: OGD; Oral-contrast swallow; RYGB; Strictures; Complications; Dysphagia;
Keywords: RYGB; Gastric bypass; Bariatric; Diabetic kidney disease; Weight loss; Renal inflammation; Urinary protein excretion; Zucker diabetic fatty rat;
Keywords: anti-CCP; anti-cyclic citrullinated peptide antibody; BMI; body mass index; CCL20; CC chemokine ligand 20; C/EBPβ; CCAAT-enhancer-binding protein β; CRP; C-reactive protein; CSF1R; colony stimulating factor 1 receptor; DAS28; disease activity score 28;
Keywords: Sleeve gastrectomy; Biliopancreatic diversion with duodenal switch; Insulin sensitivity; β-cell function; Type 2 diabetes remission; BMI; body mass index; T2D; type 2 diabetes; DI; disposition index; RYGB; Roux-in-Y gastric bypass; SG; sleeve gastrectomy
Keywords: AGB; adjustable gastric band; BMI; body mass index; CDC; Centers for Disease Control and Prevention; LSG; laparoscopic sleeve gastrectomy; NAFLD; nonalcoholic fatty liver disease; OSA; obstructive sleep apnea; RYGB; Roux-en-Y gastric bypass; T2DM; type 2
Keywords: BMI; Weight Loss Procedure; Gastric Restriction; Stomach; BMI; body mass index; BTA; botulinum toxin A; ESG; endoscopic sleeve gastroplasty; EWL; excessive weight loss; GLP-1; glucagon-like peptide 1; PYY; peptide YY; RYGB; Roux-en-Y gastric bypass;
Keywords: Gut Microbiota; Obesity; Diabetes; Fecal Transplantation; BMI; body mass index; CDI; Clostridium difficile infection; FMT; fecal microbiota transplantation; FXR; farnesoid X receptor; GF; germ-free; RYGB; roux-en-Y gastric; SCFA; short chain fatty acids;
Keywords: Bariatric Surgery; Metabolic Surgery; Weight Loss; Type 2 Diabetes; Mortality; AGB; adjustable gastric banding; BMI; body mass index; BPD; biliopancreatic diversion; DS; duodenal-switch; FXR; farnesoid-x receptor; GLP1; glucagon-like peptide 1; HbA1c; hem
Keywords: ANGPTL8; Angiopoietin-like protein 8; SAT; Subcutaneous adipose Tissue; VAT; Visceral adipose Tissue; WAT; White adipose tissue; T2DM; Type 2 diabetes mellitus; ANGPTL3; Angiopoietin-like protein 3; TG; Triglycerides; HDL; High-density lipoprotein; LDL; L
Keywords: Microorganism; Gastrointestinal carcinoma; Tumor location; CagA; cytotoxin-associated gene A; CIMP; CpG island methylator phenotype; EAC; esophageal adenocarcinoma; ESCC; esophageal squamous cell carcinoma; MSI; microsatellite instability; NOD; nucleotide
Keywords: Bile Acids; FXR; TGR5; Meta-Inflammation; apo; apolipoprotein; ASBT; apical sodiumâdependent bile acid transporter; BA; bile acid; BAS; bile acid sequestrant; BAT; brown adipose tissue; BSH; bile salt hydrolase; CA; cholic acid; CCK; cholecystokinin; CD
Keywords: BMI; Body mass index; DPP-4; Dipeptidyl peptidase IV; FDA; Food and Drug Administration; GLP-1; Glucagon-like peptide 1; Hb; Hemoglobin; INGAP; Islet cell neogenesis-associated protein; RYGB; Roux-en-Y gastric bypass; T2D; Type 2 diabetes;
Keywords: BMI; body mass index; GLP-1; glucagon-like peptide 1; PYY; peptide tyrosine tyrosine; RYGB; Roux-en-Y gastric bypass;
Keywords: Apo; apolipoprotein; BMI; body mass index; BPD; biliopancreatic diversion; FGF21; fibroblast growth factor 21; FXR; farnesoid X receptor; GB; gastric bypass; GBd; gastric banding; GLP-1; glucagon-like peptide-1; HDL-C; high-density lipoprotein cholesterol
Keywords: Intestinal Adaptation; Enteroendocrine Cells; Enterohormones; GIP; BMI; body mass index; BPL; biliopancreatic limb; [18F]-FDG; [18F]-fluorodeoxyglucose; GIP; glucose-dependent insulinotropic peptide; GLP1; glucagon-like peptide-1; GLUT; glucose transporte
Keywords: LSG; laparoscopic sleeve gastrectomy; RYGB; Roux-en-Y gastric bypass; SEMS; self-expandable metal stent; S-SEMS; sleeve-customized self-expandable metallic stent;
Keywords: Diabetes; Neuropathy; Metabolic surgery; Oxidative stress; Carbonyl stress; Gastric bypass; RYGB;
Keywords: BMI; body mass index; LAGB; laparoscopic adjustable gastric band; RYGB; Roux-en-Y gastrojejunal bypass; SEMS; self-expandable metal stent; SG; sleeve gastrectomy; VBG; vertical banded gastroplasty;
Keywords: BMI; body mass index; LAGB; laparoscopic adjustable gastric band; RYGB; Roux-en-Y gastrojejunal bypass; SEMS; selfexpandable metal stent; SG; sleeve gastrectomy; VBG; vertical banded gastroplasty;
Keywords: ASGE; American Society for Gastrointestinal Endoscopy; AT; aspiration therapy; BIB; BioEnterics Intragastric Balloon; BMI; body mass index; EBT; endoscopic bariatric therapy; ESG; endoscopic sleeve gastroplasty; FDA; U.S. Food and Drug Administration; %EW
Keywords: Satiation; Satiety; Stomach; Neurohormonal; AA; amino acids; ARC; arcuate nucleus; BMI; body mass index; CCK; cholecystokinin; FFAR; free fatty acid receptor; GIP; glucose-dependent insulinotropic peptide; GLP; glucagon-like peptide; GPR120; G protein cou
Keywords: LSG; laparoscopic sleeve gastrectomy; RYGB; Roux-en-Y gastric bypass; TTS; through-the-scope;
Keywords: Insulin sensitivity; Omentectomy; Hyperinsulinemic euglycemic clamp; Bariatric surgery; Weight loss; VAT; visceral adipose tissue; NEFA; non-esterified fatty acids; RYGB; Roux en-Y gastric bypass; DEXA; dual-energy X-ray absorptiometry;
Keywords: bariatric; loss; psoriasis; surgery; treatment; weight; AGB; adjustable gastric banding; EWL; excess weight loss; GLP; glucagon-like peptide; RYGB; Roux-en-Y gastric bypass; TNF; tumor necrosis factor;
Keywords: Bariatric surgery; RYGB; Hormone; Bile acid; Microbiome
RYGB increases the satiating effect of intrajejunal lipid infusions in female rats
Keywords: RYGB; CCK; Devazepide; Lipid; Satiation; Eating; Estradiol;
Transoral outlet reduction: a comparison of purse-string with interrupted stitch technique
Keywords: GJA; gastrojejunal anastomosis; %EWL; percent excess weight loss; %RWL; percent regained weight lost; %TWL; percent total weight loss; RYGB; Roux-en-Y gastric bypass; TORe; endoscopic sutured transoral outlet reduction (TORe);
Modeling suture patterns for endoscopic gastrojejunostomy revision: Analyzing a technique to address weight regain after gastric bypass
Keywords: Gastric bypass; RYGB; Endoscopic revision; EGJR; Endoscopic suturing; Suture pattern;
Robotic platform for gastric bypass is associated with more resource utilization: an analysis of MBSAQIP dataset
Keywords: Morbid obesity; Gastric bypass; Roux-en-Y gastric bypass; RYGB; Laparoscopy; Robot;
An international, multicenter, comparative trial of EUS-guided gastrogastrostomy-assisted ERCP versus enteroscopy-assisted ERCP in patients with Roux-en-Y gastric bypass anatomy
Keywords: AE; adverse event; ASGE; American Society for Gastrointestinal Endoscopy; e-ERCP; enteroscopy-assisted ERCP; EUS-GG-ERCP; EUS-guided gastrogastrostomy-assisted ERCP; GG; gastrogastrostomy; LAMS; lumen-apposing metallic stent; OTSC; over-the-scope clip; RY
Short-Term Preoperative Weight Loss and Postoperative Outcomes in Bariatric Surgery
Keywords: EHR; electronic health record; EWL; excess weight loss; LCD; low calorie diet; LOS; length of stay; RYGB; Roux-en-Y gastric bypass; SG; vertical sleeve gastrectomy;
Takeda G Protein-Coupled Receptor 5-Mechanistic Target of Rapamycin Complex 1 Signaling Contributes to the Increment of Glucagon-Like Peptide-1 Production after Roux-en-Y Gastric Bypass
Keywords: BAs; Bile acids; Cyp7a1; Cytochrome P450 family 7 subfamily A member 1; DCA; Deoxycholic acid; FXR; Farnesoid X receptor; GLP-1; Glucagon-like peptide-1; ip; Intraperitoneal; mTOR; mechanistic target of rapamycin; mTORC1; mechanistic target of rapamycin c
Radiofrequency ablation for the treatment of weight regain after Roux-en-Y gastric bypass surgery
Keywords: EBWL; excess body weight loss; GJA; gastrojejunal anastomosis; RFA; radiofrequency ablation; RYGB; Roux-en-Y gastric bypass;
Laparoscopic gastric bypass for the treatment of type 2 diabetes: a comparison of Roux-en-Y versus single anastomosis gastric bypass
Keywords: Gastric bypass; RYGB; SAGB; T2D; ABCD score;
Spiral enteroscopy-assisted ERCP in bariatric-length Roux-en-Y anatomy: a large single-center series and review of the literature (with video)
Keywords: DBE; double-balloon enteroscopy; DEA-ERCP; deep enteroscopy-assisted endoscopic retrograde cholangiopancreatogram; EDGE; endoscopic ultrasound-directed transgastric endoscopic retrograde cholangiopancreatogram; IQR; interquartile range; LA-ERCP; laparosco
Multicenter evaluation of the clinical utility of laparoscopy-assisted ERCP in patients with Roux-en-Y gastric bypass
Keywords: G-tube; gastrostomy tube; IQR; interquartile range; LA-ERCP; laparoscopy-assisted ERCP; RYGB; Roux-en-Y gastric bypass;
Weight loss, adverse events, and loss to follow-up after gastric bypass in young versus older adults: A Scandinavian Obesity Surgery Registry study
Keywords: RYGB; Young adult; Weight loss; Adverse event; Loss to follow-up;
Guanylin and uroguanylin mRNA expression is increased following Roux-en-Y gastric bypass, but guanylins do not play a significant role in body weight regulation and glycemic control
Keywords: AAV; adeno-associated virus; DIO; diet-induced obesity; GCC; guanylyl cyclase receptor; GN; guanylin peptide; GSIS; glucose-stimulated insulin secretion; GUCA2A; guanylate cyclase activator 2A gene; GUCA2B; guanylate cyclase activator 2B gene; ISH; in sit